Recombinant Pseudomonas putida tRNA (mo5U34)-methyltransferase (cmoB)

Shipped with Ice Packs
In Stock

Description

Definition and Function

Recombinant Pseudomonas putida tRNA (mo5U34)-methyltransferase (cmoB) refers to a genetically engineered version of the tRNA methyltransferase enzyme found in the bacterium Pseudomonas putida . tRNA methyltransferases are enzymes that catalyze the addition of a methyl group to specific tRNA molecules, which are essential for protein synthesis . This modification can affect tRNA structure and function, influencing translational fidelity and efficiency . Specifically, cmoB is involved in modifying uridine at position 34 of tRNA, generating 5-methoxyuridine (mo5U34) .

Pseudomonas putida as a Host Organism

Pseudomonas putida is a metabolically versatile bacterium with diverse enzymatic capacities and a high tolerance to xenobiotics . It has become a microbial workhorse for the heterologous expression of biosynthetic pathways, enabling the production of valuable compounds from renewable resources . P. putida's intrinsic metabolism and ability to handle complex genetic manipulations make it suitable for producing natural products, including polyketides and non-ribosomal peptides .

Role of TrmJ in tRNA Methylation

TrmJ is a tRNA methyltransferase that catalyzes the formation of Cm, Um, and Am at position 32 in the tRNA anticodon loop . In Pseudomonas aeruginosa, TrmJ has been shown to confer resistance to oxidative stress . It modifies tRNA species such as tRNA Met(CAU), tRNA Trp(CCA), tRNA Gln(UUG), tRNA Pro(UGG), tRNA Pro(CGG), tRNA His(GUG), and tRNA Pro(GGG) . The loss of TrmJ can increase sensitivity to H2O2 exposure and reduce the expression of genes involved in oxidative stress response .

miaA Gene and its Effects

The miaA gene in Pseudomonas putida encodes a tRNA-isopentenyladenine transferase, which is similar to the E. coli miaA gene . The absence of MiaA-mediated modification of tRNA can affect the translational efficiency of the trp and tna operons in E. coli .

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchase method and location. Consult your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to settle the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50%, which can be used as a reference.
Shelf Life
Shelf life depends on several factors, including storage conditions, buffer composition, temperature, and the protein's inherent stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses to prevent repeated freeze-thaw cycles.
Tag Info
The tag type is determined during manufacturing.
The specific tag type is determined during production. If you require a particular tag, please specify this during your order; we will prioritize its inclusion.
Synonyms
cmoB; PP_1440tRNA U34 carboxymethyltransferase; EC 2.5.1.-
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-318
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Pseudomonas putida (strain ATCC 47054 / DSM 6125 / NCIMB 11950 / KT2440)
Target Names
cmoB
Target Protein Sequence
MIDLSPLVRR LAGTPLASWS QGLQAQLDAK LEKGHGDLDR WRGALEALPA LQPSEIDLVN GLRLDCDCDD ATRAQMRQAL MGLSPWRKGP FDLFGVHVDT EWRSDWKWSR VGPHLDLQGK RVLDVGCGNG YYQWRMLGAG ADMVIGVDPN WLFFCQFQAV QQYLPELPAW HLPFALEDLP ANLEGFDTVF SMGVFYHRRS PIEHLLALKD CLVKGGELVL ETLVIEGDEN QVLVPEDRYA QMRNVWYLPS VPALARWLRR AGFSDVRCVD VSVTSVEEQR STDWMRYQSL SDFLDPNDHS KTVEGLPAPR RATLLARK
Uniprot No.

Target Background

Function
This enzyme catalyzes the transfer of a carboxymethyl group from carboxy-S-adenosyl-L-methionine (Cx-SAM) to 5-hydroxyuridine (ho5U) at position 34 in tRNAs, resulting in the formation of 5-carboxymethoxyuridine (cmo5U).
Database Links

KEGG: ppu:PP_1440

STRING: 160488.PP_1440

Protein Families
Class I-like SAM-binding methyltransferase superfamily, CmoB family

Q&A

What is CmoB and what is its primary biological function?

CmoB is a tRNA-modifying enzyme that catalyzes carboxymethyl transfer reactions at the wobble position of specific tRNAs, resulting in the formation of 5-oxyacetyluridine (cmo5U). It belongs to the SAM-dependent methyltransferase (SDMT) superfamily but is unique in utilizing a naturally occurring SAM analog as the alkyl donor. The primary biological function of CmoB is to modify uridine at the wobble position (U34) of tRNAs, which is essential for the accurate translation of the genetic code .

In the tRNA modification pathway, CmoB specifically recognizes carboxy-S-adenosine-L-methionine (Cx-SAM) as a substrate and catalyzes the carboxymethylation of 5-hydroxyuridine (ho5U)-containing tRNAs to yield mature cmo5U-modified tRNAs. This modification enhances the ability of tRNAs to recognize multiple synonymous codons, thus expanding the decoding capabilities during protein synthesis .

How is CmoB classified enzymatically and what are its alternative nomenclatures?

CmoB is classified under EC 2.1.1.- (methyltransferases), specifically as a tRNA (mo5U34)-methyltransferase. Alternative names for this enzyme include:

  • tRNA (mo5U34)-methyltransferase

  • Methyltransferase

  • Carboxymethyl transferase

The gene encoding this enzyme is designated as cmoB, with synonyms depending on the bacterial species. For instance, in Pseudomonas syringae pv. phaseolicola, it is also known as PSPPH_3944 .

What distinguishes CmoB from other methyltransferases in the SDMT superfamily?

CmoB is distinctive within the SAM-dependent methyltransferase (SDMT) superfamily in two critical ways:

  • It is the only known member that utilizes a naturally occurring SAM analog (Cx-SAM) as the alkyl donor to fulfill a biologically meaningful function.

  • While most methyltransferases exhibit significantly reduced activities toward SAM-analogs compared to SAM (due to steric interference from bulky side chains at the sulfonium center), CmoB preferentially utilizes Cx-SAM over SAM and catalyzes an unprecedented alkyl transfer reaction .

This remarkable discrimination between Cx-SAM and SAM, despite their structural similarity and the vastly higher cellular concentration of SAM, makes CmoB a unique enzyme within its class, representing a specialized evolutionary adaptation for tRNA modification .

What is the specific reaction catalyzed by CmoB and how does it function in the tRNA modification pathway?

CmoB catalyzes the transfer of a carboxymethyl group from Cx-SAM to 5-hydroxyuridine (ho5U) at the wobble position of specific tRNAs, resulting in the formation of 5-oxyacetyluridine (cmo5U). This reaction can be represented as:

ho5U-tRNA + Cx-SAM → cmo5U-tRNA + S-adenosylhomocysteine (SAH)

The complete pathway for cmo5U formation involves multiple enzymes:

  • An unidentified enzyme first catalyzes the hydroxylation of uridine to form 5-hydroxyuridine (ho5U) at the wobble position.

  • CmoA converts prephenate and SAM to Cx-SAM and phenylpyruvate via a unique SAM-based sulfur-ylide intermediate, capturing the carbon dioxide moiety released during prephenate decarboxylation.

  • CmoB then utilizes Cx-SAM to carboxymethylate ho5U-containing tRNAs, yielding the mature cmo5U-modified tRNAs .

Interestingly, CmoB can also catalyze the formation of 5-methoxyuridine (mo5U) using SAM as a methyl donor, albeit with significantly lower efficiency. This secondary reaction appears to be a side reaction compared to its primary Cx-SAM-dependent carboxymethylation function .

How does CmoB achieve selectivity for Cx-SAM over the more abundant SAM?

CmoB exhibits remarkable discrimination between Cx-SAM and SAM through several mechanisms:

  • Binding Affinity Difference: CmoB has approximately 500-fold higher binding affinity for Cx-SAM (Kd = 0.4 μM) compared to SAM (Kd = 200 μM) .

  • Structural Determinants: High-resolution structures of apo- and Cx-SAM-bound CmoB reveal specific structural features that favor Cx-SAM binding.

  • Chemical Selectivity: Additional contributions to selectivity arise from chemical and/or physical steps occurring after substrate binding.

What makes this selectivity even more remarkable is that the cellular concentrations of Cx-SAM (0.5 μM) and SAM (180 μM) would theoretically result in comparable occupancy of CmoB's catalytic sites based solely on binding affinities. This suggests that catalytic efficiency for the carboxymethyl transfer is significantly higher than for the methyl transfer reaction .

The table below summarizes the comparative parameters for CmoB's interaction with its substrates:

ParameterCx-SAMSAM
Binding Affinity (Kd)0.4 μM200 μM
Cellular Concentration0.5 μM180 μM
Relative ActivityHighNegligible in presence of Cx-SAM
Primary Productcmo5Umo5U (minor product)

What experimental evidence confirms the dual activity of CmoB in tRNA modification?

Both in vivo and in vitro studies have provided evidence for CmoB's dual activity in tRNA modification:

  • In vivo studies:

    • Total tRNA from wild-type E. coli contains predominantly cmo5U with trace amounts of mo5U.

    • Δcmo A mutants (unable to synthesize Cx-SAM) accumulate ho5U and mo5U, but no cmo5U.

    • Δcmo B mutants accumulate only ho5U, with neither mo5U nor cmo5U detected.

    • Complementation experiments with inducible cmoB expression in cmoB-deficient cells showed cmo5U appearing 3 hours post-induction, while mo5U only began to appear after 6 hours .

  • In vitro studies:

    • Biochemical assays demonstrate CmoB's carboxymethyl transferase activity using Cx-SAM.

    • The SAM-dependent methyltransferase activity of CmoB is negligible compared to its Cx-SAM-dependent carboxymethylation activity.

    • No significant SAM-dependent methylation activity is observed in the presence of Cx-SAM, indicating preferential utilization of Cx-SAM when both substrates are available .

These findings collectively confirm that while CmoB can catalyze both reactions, its predominant biological function is the Cx-SAM-dependent carboxymethylation of wobble ho5U in tRNA, with SAM-dependent methyltransfer representing a secondary activity .

What is the functional importance of cmo5U modification in bacterial translation?

The cmo5U modification at the wobble position of tRNAs plays a critical role in expanding the decoding capabilities of tRNAs during protein synthesis. This modification allows certain tRNAs to recognize multiple synonymous codons, enhancing translational efficiency and accuracy. While the complete functional description of cmo5U modification remains to be fully defined, several important aspects have been established:

  • The modification enables broader codon recognition, allowing a single tRNA to decode multiple codons that differ at the third position.

  • This expanded decoding capacity is essential for efficient translation of the genetic code, particularly for organisms with diverse codon usage patterns.

  • The modification may contribute to translational fidelity and protein folding dynamics by influencing the rate of translation at specific codons .

Interestingly, while no obvious growth defects have been reported for cmoA- or cmoB-knockout mutants in laboratory strains like E. coli K-12 under standard conditions, fitness effects become apparent under specific environmental conditions or in certain bacterial species .

How widely is CmoB conserved across bacterial species and what does this suggest about its evolutionary importance?

Sequence analysis reveals widespread conservation of CmoB orthologs, suggesting its evolutionary significance:

  • CmoB is highly conserved among Gram-negative proteobacteria.

  • Orthologs are also found in some Verrucomicrobia, Acidobacteria, and Cyanobacteria .

This broad conservation pattern indicates that the cmo5U modification system likely confers significant selective advantages across diverse bacterial lineages, despite the apparent lack of strong phenotypes in laboratory conditions for some species.

The table below summarizes the distribution of CmoB across bacterial phyla:

Bacterial PhylaPresence of CmoB Orthologs
Proteobacteria (Gram-negative)Widely distributed
VerrucomicrobiaPresent in some species
AcidobacteriaPresent in some species
CyanobacteriaPresent in some species

What phenotypes are associated with cmoB mutations in different bacterial species?

The phenotypic consequences of cmoB mutations vary across bacterial species and environmental conditions:

  • E. coli K-12: No obvious growth defects have been reported under standard laboratory conditions for cmoB-knockout mutants .

  • Uropathogenic E. coli CFT073: The related cmoA gene was classified as a candidate fitness gene required for optimal survival in the mouse spleen, suggesting potential virulence-related functions of the cmo5U modification system .

  • Shewanella oneidensis MR-1: Fairly strong fitness defects have been reported for both cmoA and cmoB mutants when grown at pH 6 or using N-acetylglucosamine as a carbon source .

These observations suggest that the functional importance of cmo5U modification becomes more apparent under specific stress conditions or in particular ecological niches, highlighting its role in adaptive responses rather than in basic cellular functions under optimal growth conditions .

What are the recommended methods for purifying and handling recombinant CmoB?

Based on available information about recombinant CmoB production and handling:

  • Expression Systems:

    • E. coli expression systems are commonly used for recombinant CmoB production

    • Alternative expression hosts include yeast, baculovirus, or mammalian cell systems depending on research requirements

  • Purification Parameters:

    • Affinity chromatography methods can achieve >90% purity

    • The protein is typically maintained in liquid form containing glycerol

  • Storage Conditions:

    • For long-term storage: -20°C or -80°C

    • Working aliquots can be stored at 4°C for up to one week

    • Repeated freezing and thawing should be avoided to maintain enzyme activity

When designing experiments with recombinant CmoB, it's important to consider the enzyme's stability and activity requirements. The presence of glycerol in storage buffers helps maintain protein stability, while avoiding repeated freeze-thaw cycles prevents activity loss .

How can CmoB activity be measured in vitro?

Several complementary approaches can be employed to measure CmoB activity in vitro:

  • Radiometric Assays:

    • Using radiolabeled Cx-SAM or SAM to detect transfer of methyl or carboxymethyl groups to tRNA substrates

    • Quantification via liquid scintillation counting after isolating modified tRNAs

  • LC-MS/MS Analysis:

    • Digestion of modified tRNAs with P1 nuclease followed by LC-MS/MS analysis

    • This approach allows detection and quantification of modified nucleosides including ho5U, mo5U, and cmo5U

    • The approach was successfully used to detect tRNA modifications in vivo by analyzing P1 nuclease-treated total tRNA from wild-type and mutant E. coli strains

  • Binding Affinity Measurements:

    • Determination of binding affinities for Cx-SAM and SAM using techniques such as isothermal titration calorimetry or fluorescence polarization

    • These measurements revealed the ~500-fold difference in binding affinities between Cx-SAM (Kd = 0.4 μM) and SAM (Kd = 200 μM)

When designing activity assays, it's important to consider the presence of both SAM and Cx-SAM, as CmoB can utilize both substrates with differing efficiencies .

What structural biology approaches have provided insights into CmoB mechanism?

High-resolution structural studies have been instrumental in understanding CmoB's mechanism and substrate specificity:

  • X-ray Crystallography:

    • Crystal structures of both apo-CmoB and Cx-SAM-bound CmoB have been determined

    • These structures revealed the determinants responsible for discrimination between Cx-SAM and SAM

  • Structural Comparisons:

    • Comparison of CmoB with other members of the SAM-dependent methyltransferase (SDMT) superfamily has highlighted unique features of CmoB

    • Analysis of the active site architecture explains how CmoB accommodates the bulkier Cx-SAM substrate compared to other methyltransferases that preferentially use SAM

  • Structure-Function Analysis:

    • The structural data provided mechanistic insight into the enzymatic features that allow CmoB to achieve selectivity for Cx-SAM over the more abundant SAM

    • Complementary biochemical and genetic studies have confirmed the structural insights

These structural biology approaches have been pivotal in establishing CmoB as a unique member of the SDMT superfamily that preferentially utilizes a SAM analog and catalyzes an unprecedented alkyl transfer reaction .

How might CmoB be used as a tool in RNA biology research?

CmoB offers several potential applications as a research tool in RNA biology:

  • RNA Modification Studies:

    • CmoB could be used to introduce carboxymethyl modifications into specific RNA molecules in vitro

    • This would enable studies on the impact of such modifications on RNA structure, stability, and function

  • Codon Recognition Analysis:

    • The enzyme could be employed to study how specific tRNA modifications affect codon recognition

    • By comparing translation efficiency with modified versus unmodified tRNAs, researchers could gain insights into the role of wobble modifications in codon bias and translational regulation

  • Probe Development:

    • Engineered variants of CmoB might be developed as tools to detect or label specific RNA structures

    • The enzyme's natural specificity for tRNA substrates could be harnessed to create targeted RNA modification tools

The unique substrate specificity of CmoB makes it particularly valuable for studying the biological role of carboxymethylated RNA modifications and their impact on translation processes .

What are the current challenges in studying tRNA modification enzymes like CmoB?

Several challenges remain in the study of tRNA modification enzymes like CmoB:

  • Substrate Availability:

    • The natural substrate Cx-SAM is not commercially available and must be enzymatically synthesized

    • Generating sufficient quantities of properly folded tRNA substrates for in vitro studies can be technically challenging

  • Functional Redundancy:

    • The lack of obvious growth defects in cmoB mutants under standard laboratory conditions suggests functional redundancy or condition-specific importance

    • This complicates the assessment of the biological significance of cmo5U modifications

  • Temporal Dynamics:

    • Understanding the timing and regulation of tRNA modifications during different growth phases and stress conditions remains difficult

    • Current methods typically provide static snapshots rather than dynamic information about modification processes

  • Structural Complexities:

    • While structures of apo-CmoB and Cx-SAM-bound CmoB have been determined, structures of the enzyme bound to tRNA substrates would provide additional mechanistic insights

    • Such complex structures are technically challenging to obtain due to the flexibility and size of tRNA molecules

Addressing these challenges will require continued development of sensitive analytical methods, improved genetic tools, and advanced structural biology approaches .

What unresolved questions about CmoB warrant further investigation?

Several key questions about CmoB remain unanswered and represent fruitful areas for future research:

  • Regulation Mechanisms:

    • How is CmoB expression and activity regulated in response to different environmental conditions?

    • Are there post-translational modifications that affect CmoB function?

  • Substrate Recognition:

    • What are the precise determinants of tRNA recognition by CmoB?

    • How does CmoB specifically recognize ho5U in the wobble position?

  • Evolutionary History:

    • Why do some bacterial species maintain the cmo5U modification system while others do not?

    • What selective pressures drove the evolution of the unique Cx-SAM-dependent carboxymethylation system?

  • Physiological Role:

    • What is the complete physiological significance of cmo5U modifications in different bacterial species?

    • Why do cmoB mutations show fitness defects only under specific conditions, such as in Shewanella oneidensis MR-1 when grown at pH 6 or using N-acetylglucosamine as a carbon source?

  • Identification of Related Enzymes:

    • The enzyme responsible for the initial hydroxylation of uridine to ho5U remains unidentified

    • Are there other enzymes in the pathway that remain to be discovered?

Research addressing these questions would significantly advance our understanding of tRNA modification processes and their roles in bacterial physiology and adaptation .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.